CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-04-09 | FRIEDMANN NADAV Chief Operating Officer | Shares withheld for taxes | −98,075 | $5.65 | $554K | 336,229 |
| 2014-04-09 | FRIEDMANN NADAV Chief Operating Officer | Option exercise · Common Stock | −122,054 | $4.54 | $554K | 3,289,869 |
| 2014-03-21 | ROBERTSON SANFORD Director | Option exercise | +42,897 | $4.49 | $193K | 412,624 |
| 2014-03-21 | ROBERTSON SANFORD Director | Option exercise | +25,738 | $4.69 | $121K | 438,362 |
| 2014-03-21 | ROBERTSON SANFORD Director | Option exercise · (1) Common Stock | +42,897 | $4.49 | $193K | 607,136 |
| 2014-03-21 | ROBERTSON SANFORD Director | Option exercise · (1) Common Stock | +25,738 | $4.69 | $121K | 581,398 |
| 2014-03-21 | O DONNELL MICHAEL J Director | Option exercise | +42,897 | $4.49 | $193K | 66,948 |
| 2014-03-21 | O DONNELL MICHAEL J Director | Shares withheld for taxes | −34,830 | $5.53 | $193K | 32,118 |
| 2014-03-21 | O DONNELL MICHAEL J Director | Option exercise · Common Stock | −42,897 | $4.49 | $193K | 372,750 |
| 2013-12-12 | BARBIER REMI CEO, Chairman of the Board | Option exercise | +39,637 | $3.65 | $145K | 2,153,762 |
| 2013-11-06 | ROBERTSON SANFORD Director | Purchase | +31,838 | $3.76 | $120K | 369,727 |
| 2013-11-04 | ROBERTSON SANFORD Director | Purchase | +18,162 | $3.69 | $67K | 337,889 |
| 2013-06-14 | GUSSIN ROBERT Z Director | Grant or award · Non-Qualifying Stock Options (1) | +25,000 | $2.38 | $60K | 635,033 |
| 2013-06-14 | GUSSIN ROBERT Z Director | Grant or award · Non-Qualifying Stock Options (2) | +15,000 | $2.38 | $36K | 650,033 |
| 2013-06-14 | ROBERTSON SANFORD Director | Grant or award · Non-Qualifying Stock Options (1) | +25,000 | $2.38 | $60K | 660,771 |
| 2013-06-14 | ROBERTSON SANFORD Director | Grant or award · Non-Qualifying Stock Options (2) | +15,000 | $2.38 | $36K | 675,771 |
| 2013-06-14 | O DONNELL MICHAEL J Director | Grant or award · Non-Qualifying Stock Options (1) | +25,000 | $2.38 | $60K | 415,647 |
| 2013-06-14 | SCANNON PATRICK J MD PHD Director | Grant or award · Non-Qualifying Stock Options (1) | +25,000 | $2.38 | $60K | 429,128 |
| 2013-06-14 | Ramasastry Saira Director | Grant or award · Non-Qualifying Stock Options (1) | +25,000 | $2.38 | $60K | 75,000 |
| 2013-06-14 | Ramasastry Saira Director | Grant or award · Non-Qualifying Stock Options (2) | +15,000 | $2.38 | $36K | 90,000 |
Page 15 of 17 · 324 trades